000 01331 a2200349 4500
005 20250518100159.0
264 0 _c20201201
008 202012s 0 0 eng d
022 _a1573-7217
024 7 _a10.1007/s10549-020-05640-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMiyashita, Hirotaka
245 0 0 _aBone modifying agents for bone loss in patients with aromatase inhibitor as adjuvant treatment for breast cancer; insights from a network meta-analysis.
_h[electronic resource]
260 _bBreast cancer research and treatment
_cJun 2020
300 _a279-289 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Review
650 0 4 _aAromatase Inhibitors
_xadverse effects
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aBone Density Conservation Agents
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aOsteoporosis
_xchemically induced
650 0 4 _aPrognosis
700 1 _aSatoi, Sera
700 1 _aKuno, Toshiki
700 1 _aCruz, Christina
700 1 _aMalamud, Stephen
700 1 _aKim, Se-Min
773 0 _tBreast cancer research and treatment
_gvol. 181
_gno. 2
_gp. 279-289
856 4 0 _uhttps://doi.org/10.1007/s10549-020-05640-3
_zAvailable from publisher's website
999 _c30885371
_d30885371